Skip to main content
Log in

Association between TAFI and PAI-1 polymorphisms with biochemical and hemostatic parameters in polycystic ovary syndrome

  • Correspondence
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Godtfredsen AC, Sidelmann JJ, Gram JB, Andersen M, Glintborg D (2020) Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 99(8):1078–1084. https://doi.org/10.1111/aogs.13825

    Article  CAS  PubMed  Google Scholar 

  2. Martínez-García M, Moncayo S, Insenser M, Álvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF (2019) Metabolic cytokines at fasting and during macronutrient challenges: influence of obesity, female androgen excess and sex. Nutrients 11(11):2566. https://doi.org/10.3390/nu11112566

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Claesen K, Mertens JC, Leenaerts D, Hendriks D (2021) Carboxypeptidase U (CPU, TAFIa, CPB2) in thromboembolic disease: what do we know three decades after its discovery? Int J Mol Sci 22(2):883. https://doi.org/10.3390/ijms22020883

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Salazar Garcia MD, Sung N, Mullenix TM, Dambaeva S, Beaman K, Gilman-Sachs A et al (2016) Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with reproductive failure: metabolic, hormonal, and immune profiles. Am J Reprod Immunol 76(1):70–81. https://doi.org/10.1111/aji.12516

    Article  CAS  PubMed  Google Scholar 

  5. Parpugga TK, Tatarunas V, Skipskis V, Kupstyte N, Zaliaduonyte-Peksiene D, Lesauskaite V (2015) The effect of PAI-1 4G/5G polymorphism and clinical factors on coronary artery occlusion in myocardial infarction. Dis Mark. https://doi.org/10.1155/2015/260101

    Article  Google Scholar 

Download references

Funding

FAPEMIG, APQ-00812-12, Cláudia Natália Ferreira.

Author information

Authors and Affiliations

Authors

Contributions

JCA, KBG, CNF protocol/project development, data collection and management, data analysis, manuscript writing/editing. NMCL, THOR and FSS methodology support. LBXC, FMR and HJR, data analysis, manuscript writing/editing. ALC and IFOS data analysis.

Corresponding author

Correspondence to Cláudia N. Ferreira.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that would cause detriment to the impartiality of this scientific work. The Authors of the manuscript entitled association between TAFI and PAI-1 polymorphisms with biochemical and hemostatic parameters in polycystic ovary syndrome declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albuquerque, J.C., Luz, N.M.C., Ribeiro, T.H.O. et al. Association between TAFI and PAI-1 polymorphisms with biochemical and hemostatic parameters in polycystic ovary syndrome. Arch Gynecol Obstet 307, 1311–1314 (2023). https://doi.org/10.1007/s00404-022-06632-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-022-06632-y

Navigation